Nelipepimut S Uses, Dosage, Side Effects and more
| Trade Name | Nelipepimut S |
| Generic | Nelipepimut-S |
| Nelipepimut-S Other Names | Nelipepimut S, Nelipepimut-S |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in prostate cancer and breast cancer.
How Nelipepimut S works
NeuVax is a HER2/neu peptide-based T-cell immunotherapy aimed at preventing disease recurrence and prolonging survival in cancer patients that have tumors which express the HER2/neu oncoprotein. To date, clinical study results have demonstrated that NeuVax significantly reduces the rate of cancer recurrence while showing minimal side effects. [Apthera Press release]
